QQ客服 官方微博 反馈留言

	ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype
	Zhong Ying; Shen Songjie; Zhou Yidong; Mao Feng; Guan Jinghong; Lin Yan; Xu Yali; Sun Qiang
	2014
卷号	31期号:3页码:864
ISSN号	1559-131X
DOI	10.1007/s12032-014-0864-0
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6671037
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhong Ying,Shen Songjie,Zhou Yidong,et al. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype[J],2014,31(3):864.
APA	Zhong Ying.,Shen Songjie.,Zhou Yidong.,Mao Feng.,Guan Jinghong.,...&Sun Qiang.(2014).ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.,31(3),864.
MLA	Zhong Ying,et al."ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype".31.3(2014):864.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。